BRIEF published on 07/17/2025 at 07:04, 6 months 24 days ago Medartis finalise l'acquisition complète de KeriMedical Approbation De La FDA KeriMedical Acquisition De Medartis Remplacement Articulaire Prothèse TOUCH
BRIEF published on 07/17/2025 at 07:04, 6 months 24 days ago Medartis Finalizes Full Acquisition of KeriMedical FDA Approval Medartis Acquisition KeriMedical Joint Replacement TOUCH Prosthesis
PRESS RELEASE published on 07/17/2025 at 06:59, 6 months 24 days ago Medartis acquires remaining 53% stake in KeriMedical Medartis acquires remaining 53% stake in KeriMedical, strengthening position in joint replacement & expanding surgeon network. Acquisition valued at CHF 99 million in cash with FDA-approved flagship product TOUCH Acquisition FDA Approval Medartis KeriMedical Joint Replacement
PRESS RELEASE published on 03/18/2025 at 06:59, 10 months 23 days ago Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
PRESS RELEASE published on 08/20/2024 at 07:05, 1 year 5 months ago Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
BRIEF published on 07/09/2024 at 07:04, 1 year 7 months ago Matthias Schupp nommé PDG de Medartis Technologie Médicale Nomination Du PDG Medartis Matthias Schupp
BRIEF published on 07/09/2024 at 07:04, 1 year 7 months ago Matthias Schupp Appointed as CEO of Medartis Medical Technology CEO Appointment Medartis Matthias Schupp
PRESS RELEASE published on 07/09/2024 at 06:59, 1 year 7 months ago Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis Medartis appoints Matthias Schupp as CEO, succeeding Christoph Brönnimann. Schupp brings extensive experience in the medical technology sector CEO Appointment Leadership Transition Medartis Matthias Schupp Medical Technology Sector
BRIEF published on 06/11/2024 at 07:04, 1 year 7 months ago Medartis annonce la démission de son PDG Christoph Brönnimann Démission Du PDG Direction D'entreprise Transition D'entreprise Medartis Christoph Brönnimann
BRIEF published on 06/11/2024 at 07:04, 1 year 7 months ago Medartis Announces Resignation of CEO Christoph Brönnimann Corporate Leadership CEO Resignation Business Transition Medartis Christoph Brönnimann
Published on 02/10/2026 at 15:00, 16 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 14:30, 46 minutes ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 1 hour 16 minutes ago Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7
Published on 02/10/2026 at 14:00, 1 hour 16 minutes ago BTU Metals Initiates Geophysical Program at Its Dixie East Property in Red Lake in Preparation for Drilling Drilling Planned for Three Ontario Gold Projects in 2026
Published on 02/10/2026 at 15:09, 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 02/10/2026 at 15:07, 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 02/10/2026 at 15:06, 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 02/09/2026 at 18:00, 21 hours 16 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 21 hours 31 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 21 hours 31 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 21 hours 31 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 21 hours 31 minutes ago Déclaration des droits de vote à fin janvier 2026
